Healthcare is one of the industries most rapidly adopting Artificial Intelligence and other cutting edge technologies, especially where innovation plays a leading role in reducing costs and optimizing processes. The integration of such technologies in the drug evaluation processes—from risk prediction to diagnosis, and from prognosis to therapy—combined with new discoveries in the field of genetics is accelerating processes that would have previously required more time and resources, both human and economic.
DataForce Partnered with the Italian Association for Digital Health and Telemedicine and a number of distinguished scientists to co-author and translate 150 pages on the most debated aspects of AI in Healthcare. From governance, to bias and specialized applications for mental health, this journal addresses candidly the current problems and opportunities presented by AI for Health professionals and patients alike.
To learn more about AISDET visit their website here